This Swedish nationwide longitudinal research included 192 sufferers who underwent esophagectomy for most cancers. The publicity was dispositional optimism measured by the Life Orientation Check-Revised (LOT-R) at 1 yr post-surgery. Sufferers have been categorized into 4 subgroups (very low, reasonably low, reasonably excessive, and really excessive dispositional optimism) primarily based on the quartile of the LOT-R sum rating. The result was HRQL assessed by the European Group for Analysis and Therapy of Most cancers High quality of Life Questionnaire-Core 30 and High quality of Life Questionnaire-Esophago-Gastric module 25 at 1, 1.5, and a couple of years post-surgery.
Linear mixed-effects fashions, adjusted for potential confounders, have been used to look at the imply rating distinction (MSD) with 95% confidence interval of HRQL among the many 4 affected person subgroups. Sufferers with very excessive dispositional optimism reported clinically relevantly higher world high quality of life, emotional perform, and social perform (MSD vary 10-16) and fewer extreme signs in ache, dyspnea, diarrhea, consuming problem, anxiousness, dry mouth, bother with style, fear about weight reduction, and self-doubt about physique picture (MSD vary – 9 to – 22) than sufferers with decrease dispositional optimism.
Sufferers with reasonably excessive dispositional optimism reported clinically and statistically considerably higher world high quality of life (MSD 10) and fewer extreme diarrhea (MSD – 9) than sufferers with decrease dispositional optimism. Adjusted MSDs have been fixed over the three time factors in all features aside from consuming problem. Subsequently, the DF-based SA successfully solves the issue of fabric shedding and growing older, thus enhancing the soundness and injury threshold of the fiber laser.
COVID-19: unbalanced administration of occupational risks-case of the evaluation of the chemical threat associated to the usage of disinfectants within the dairy business in Morocco
Moroccan employers have a robust duty for the security and well being of their staff within the office and for shielding them from the chance of COVID-19 and any occupational hazards, as required by Moroccan legislation. As a consequence, industries, together with the agri-food sector, have put in place preventive measures to cope with this pandemic on a number of fronts, together with the usage of hydroalcoholic merchandise and bleach for private and floor disinfection.
These disinfection actions might remove or scale back the chance of coronavirus an infection, however the elevated use of those merchandise by staff may result in critical well being issues and improve the occupational chemical threat within the occasion of uncontrolled publicity. With the intention to analyze this threat within the dairy business in Morocco, we now have launched a qualitative and quantitative research to establish and assess the severity of chemical threat to which its staff are uncovered.
This includes an evaluation of the security information sheets [MSDS] of the disinfectants used and a well being and security survey of the customers of those merchandise, significantly for hand disinfection. This evaluation confirmed that this chemical threat is omnipresent and prevention measures are partially adopted. Certainly, the strengthening of well being security measures to fight COVID-19 has considerably elevated this threat, leading to a outstanding imbalance within the evaluation and administration of occupational dangers on this business.
That is the usage of the Danger Evaluation-Important Management Factors (HACCP)-Instrument for a First Danger Evaluation by Exercise Evaluation (OPERA) method, which we developed and proposed in a earlier research, for a simplified administration of chemical threat within the meals business, particularly in small- and medium-sized enterprises. These outcomes have led us to suggest corrective and preventive measures towards this threat to events and to undertake an built-in administration of meals and occupational well being dangers in a single system.
Monitoring-based deep studying methodology for temporomandibular joint segmentation
The form, measurement, and floor info regarding the glenoid fossae and condyles in temporomandibular joints (TMJ) are important for diagnosing and treating. Sufferers with TMJ illness usually have floor abrasion which can trigger fuzzy edges in computed tomography (CT) imaging, particularly for low-dose CT, making TMJ segmentation harder. On this paper, an computerized segmentation algorithm primarily based on deep studying and post-processing was launched.
First, U-Internet was used to divide photos into three classes: glenoid fossae, condyles, and background. For structural fractures in these divided photos, the inner pressure constraint of a snake mannequin was used to replenish the integrity of the fracture boundary in a post-processing operation, and the preliminary boundary of the snake was obtained primarily based on the idea of the monitoring idea. A complete of 206 instances of low-dose CT have been used to confirm the effectiveness of the algorithm, and such indicators because the Cube coefficient (DC) and imply floor distance (MSD) have been used to judge the settlement between experimental outcomes and the gold normal.
E. coli gyrase ATPase assay Kit Plus (enzyme included) |
T2A-100KE |
ProFoldin |
100 assays |
EUR 444.91 |
Description: This product includes the reaction buffer, DNA, E. coli gyrase, ATP and the phosphate detection reagent for 100 assays of DNA supercoiling reactions in a 384-well assay format. |
P. aeruginosa Gyrase ATPase assay Kit Plus (enzyme included) |
T2A-100KP |
ProFoldin |
100 assays |
EUR 444.91 |
Description: This product includes the reaction buffer, DNA, P. aeruginosa gyrase, ATP and the phosphate detection reagent for 100 assays of DNA supercoiling reactions in a 384-well assay format. |
S. aureus gyrase ATPase assay Kit Plus (enzyme included) |
T2A-100KS |
ProFoldin |
100 assays |
EUR 423.72 |
Description: This product includes the reaction buffer, DNA, S. aureus gyrase, ATP and the phosphate detection reagent for 100 assays of DNA supercoiling reactions in a 384-well assay format. |
CD28 antigen (CD28) polyclonal antibody |
ABP-PAB-10144 |
Allele Biotech |
100 ug |
Ask for price |
|
pCDH-CuO-MCS-T2A-GFP co-inducible T2A lentivector |
QM521A-1 |
SBI |
10 ug |
EUR 814.8 |
|
pCDH-CuO-MCS-T2A-RFP co-inducible T2A lentivector |
QM522A-1 |
SBI |
10 ug |
EUR 814.8 |
|
CD28 siRNA |
20-abx910984 |
Abbexa |
|
|
|
CD28 siRNA |
20-abx910985 |
Abbexa |
|
|
|
CD28 Antibody |
1-CSB-PA005199 |
Cusabio |
|
|
|
Description: A polyclonal antibody against CD28. Recognizes CD28 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
CD28 antibody |
70R-49503 |
Fitzgerald |
100 ul |
EUR 344.4 |
Description: Purified Polyclonal CD28 antibody |
CD28 antibody |
70R-CR045 |
Fitzgerald |
100 ug |
EUR 360 |
Description: Affinity purified Rabbit polyclonal CD28 antibody |
CD28 antibody |
70R-9669 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Affinity purified rabbit polyclonal CD28 antibody |
CD28 Antibody |
46435-100ul |
SAB |
100ul |
EUR 302.4 |
CD28 Peptide |
42-404P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: (IN) CD28 Peptide |
Cd28 Peptide |
42-448P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: (IN) Cd28 Peptide |
CD28 antibody |
10R-6375 |
Fitzgerald |
100 ug |
EUR 230.4 |
Description: Syrian Hamster monoclonal CD28 antibody |
CD28 antibody |
10R-6376 |
Fitzgerald |
100 ug |
EUR 230.4 |
Description: Mouse monoclonal CD28 antibody |
CD28 antibody |
10R-CD28bHU |
Fitzgerald |
100 ul |
EUR 560.4 |
Description: Mouse monoclonal CD28 antibody |
CD28 antibody |
10R-CD28dCKp |
Fitzgerald |
500 ug |
EUR 483.6 |
Description: Mouse monoclonal CD28 antibody |
CD28 antibody |
10R-CD28dMS |
Fitzgerald |
500 ug |
EUR 444 |
Description: Hamster monoclonal CD28 antibody |
CD28 antibody |
10R-CD28eMS |
Fitzgerald |
500 ug |
EUR 444 |
Description: Hamster monoclonal CD28 antibody |
CD28 siRNA |
20-abx900903 |
Abbexa |
|
|
|
CD28 Antibody |
8683-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: N/A |
CD28 Antibody |
8683-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: N/A |
CD28 Peptide |
8683P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: CD28 peptide |
CD28/TP44 |
E21-D81 |
EnoGene |
10ug |
EUR 411.6 |
anti-CD28 |
YF-PA10780 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to CD28 |
CD28 Antibody |
V8232-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V8232-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V8232SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V8233-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V8233-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V8233SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2051-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical Tcell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing Tcells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. it is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2051-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical Tcell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing Tcells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. it is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2051CF488-100T |
NSJ Bioreagents |
100 Tests |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2051PE-100T |
NSJ Bioreagents |
100 Tests |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2051SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical Tcell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing Tcells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. it is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2053-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2053-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2053SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2054-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2054-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2054SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: This antibody recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2987-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2987-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V2987SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: Recognizes a glycoprotein of 44-88kDa, which is identified as CD28. It is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V3258-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD28 is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V3258-20UG |
NSJ Bioreagents |
20 ug |
EUR 219 |
Description: CD28 is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
CD28 Antibody |
V3258SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 499 |
Description: CD28 is the critical T-cell co-stimulatory receptor which provides to the cell the important second activation signal by binding CD80 and CD86 that are expressed by antigen presenting cells. Besides its co-stimulation role, CD28 functions in preventing T-cells from anergic hyporesponsive state or from undergoing premature apoptotic cell death. CD28 is also expressed on human fetal NK cells and some NK cell lines, whereas on murine NK cells the CD28 expression is much broader. |
Recombinant Cynomolgus CD28 molecule/CD28(C-Fc) |
CB24-10ug |
Novoprotein |
10ug |
EUR 120 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Cynomolgus CD28 molecule/CD28(C-Fc) |
CB24-1mg |
Novoprotein |
1mg |
EUR 1338 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Cynomolgus CD28 molecule/CD28(C-Fc) |
CB24-500ug |
Novoprotein |
500ug |
EUR 936 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Cynomolgus CD28 molecule/CD28(C-Fc) |
CB24-50ug |
Novoprotein |
50ug |
EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
T-cell-specific surface glycoprotein CD28/CD28 |
E21-I67 |
EnoGene |
10ug |
EUR 411.6 |
T2A-GFP Co-Expression HR Targeting Vector [T2A-GFP-pA-loxP-EF1?-RFP-T2A-Puro-pA-LoxP-MCS] |
HR130PA-1 |
SBI |
10 ug |
EUR 1227.6 |
|
Anti-CD19 CAR Lentivirus (CD19 ScFv-CD8-4-1BB-CD3ζ) |
78600 |
BPS Bioscience |
50 µl |
EUR 1150 |
Description: The anti-CD19 CAR lentiviruses are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. These viruses constitutively express the ScFv portion of anti-CD19 (clone FMC63) linked to 2nd generation CAR (Chimeric Antigen Receptor) containing CD8 hinge, 4-1BB, and CD3ζ signaling domains. |
pCDH-EF1-MCS*-T2A-GFP |
CD526A-1 |
SBI |
10 ug |
EUR 783.6 |
|
CD28(204.12) Antibody |
BNCA0164-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD28(204.12), APC conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCA0384-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD28(CB28), APC conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCAP0164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCAP0164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCAP0384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCAP0384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
CD28 Polyclonal Antibody |
ABP52975-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of CD28 from Human. This CD28 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD28 |
CD28 Polyclonal Antibody |
ABP52975-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of CD28 from Human. This CD28 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD28 |
CD28 Polyclonal Antibody |
ABP52975-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of CD28 from Human. This CD28 antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human CD28 |
CD28(204.12) Antibody |
BNC610164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF660R conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC610164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF660R conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC610384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF660R conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC610384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF660R conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC680164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF568 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC680164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF568 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC680384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF568 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC680384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF568 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCR0164-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD28(204.12), RPE conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCR0384-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD28(CB28), RPE conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNUB0164-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against CD28(204.12), Concentration: 0.2mg/mL |
CD28(204.12) Antibody |
BNUB0164-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against CD28(204.12), Concentration: 0.2mg/mL |
CD28(CB28) Antibody |
BNUB0384-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against CD28(CB28), Concentration: 0.2mg/mL |
CD28(CB28) Antibody |
BNUB0384-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against CD28(CB28), Concentration: 0.2mg/mL |
CD28(204.12) Antibody |
BNC430164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF543 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC430164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF543 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC430384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF543 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC430384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF543 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC470164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF647 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC470164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF647 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC470384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF647 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC470384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF647 conjugate, Concentration: 0.1mg/mL |
CD28 Blocking Peptide |
AF0014-BP |
Affbiotech |
1mg |
EUR 234 |
CD28(204.12) Antibody |
BNC400164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF640R conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC400164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF640R conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC400384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF640R conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC400384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF640R conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC880164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF488A conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC880164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF488A conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC880384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF488A conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC880384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF488A conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC810164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF680R conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC810164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF680R conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC810384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF680R conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC810384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF680R conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCP0164-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD28(204.12), PerCP conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCP0384-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against CD28(CB28), PerCP conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNUM0164-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against CD28(204.12), 1mg/mL |
CD28(CB28) Antibody |
BNUM0384-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against CD28(CB28), 1mg/mL |
CD28(204.12) Antibody |
BNC050164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF405M conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC050164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF405M conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC050384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF405M conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC050384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF405M conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC700164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF770 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC700164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF770 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC700384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF770 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC700384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF770 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC800164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF680 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC800164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF680 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC800384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF680 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC800384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF680 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCB0164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), Biotin conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCB0164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), Biotin conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCB0384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), Biotin conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCB0384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), Biotin conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC940164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF594 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC940164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF594 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC940384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF594 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC940384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF594 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC550164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), CF555 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNC550164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), CF555 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC550384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), CF555 conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNC550384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), CF555 conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCH0164-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(204.12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD28(204.12) Antibody |
BNCH0164-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(204.12), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCH0384-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against CD28(CB28), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
CD28(CB28) Antibody |
BNCH0384-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against CD28(CB28), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Utility of the SA in erbium-doped fiber laser and steady passive Q-switched operation with a most pulse power of 430.47 nJ is realized. By adjusting the polarization state and pump energy, high-power mode-locked pulses are generated with a pulse period and output energy of 199 fs and 54.13 mW, respectively. Additional, bound-state soliton pulses are obtained with a pulse width of 312 fs and soliton interval of 1.26 ps for the primary time primarily based on MXene supplies. Furthermore, by utility of the SA in ytterbium-doped fiber lasers, a steady dissipative soliton mode-locked pulse is obtained with a pulse width of 23 ps. These outcomes point out that the DF-based buried Mo2C as a novel SA offers a dependable methodology for all-fiber and multifunctional high-power ultrafast laser.